Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: Results with an acute dog model

This publication has 30 references indexed in Scilit:

• Lack of Effect of Lovastatin on Restenosis after Coronary Angioplasty
  New England Journal of Medicine, 1994
• The basis of molecular strategies for treating coronary restenosis after angioplasty
  Journal of the American College of Cardiology, 1994
• Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Migration of smooth muscle and endothelial cells. Critical events in restenosis.
  Circulation, 1992
• Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
  Circulation, 1992
• Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty
  Journal of the American College of Cardiology, 1992
• Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT).
  Circulation, 1991
• Thrombin and other potential mechanisms underlying restenosis.
  Circulation, 1991
• The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty
  Journal of the American College of Cardiology, 1991
• Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty
  The American Journal of Cardiology, 1987